CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioLine RX Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioLine RX Ltd
Modi'in Technology Park
2 HaMa'ayan Street
Phone: +972 86429100p:+972 86429100 MODIIN, 7177871  Israel Ticker: BLRXBLRX
Business Summary
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board AharonSchwartz 81 4/3/2003 4/3/2003
Chief Executive Officer Philip A.Serlin 60 10/10/2016 5/1/2009
Chief Financial Officer MaliZeevi 41 10/10/2016 1/1/2009
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Agalimmune Limited 2nd Floor London United Kingdom

Business Names
Business Name
Agalimmune Ltd.
BioLineRx Ltd.
BioLineRx USA Inc.
BLRX

General Information
Number of Employees: 79 (As of 12/31/2023)
Outstanding Shares: 1,199,859,190 (As of 8/28/2024)
Stock Exchange: TLV
Fax Number: +972 86429101


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024